Patent details

EP1124539 Title: PHARMACEUTICAL FORMULATION COMPRISING OMEPRAZOLE

Basic Information

Publication number:
EP1124539
PCT Application Number:
PCT/SE/99/01989
Type:
European Patent Granted for LU
Legal Status:
Surrendered
Application number:
EP999717036
PCT Publication Number:
WO/00/02736
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
PHARMACEUTICAL FORMULATION COMPRISING OMEPRAZOLE
French Title of Invention:
FORMULATION PHARMACEUTIQUE CONTENANT DE L'OMEPRAZOLE
German Title of Invention:
PHARMAZEUTISCHE FORMULIERUNG MIT OMEPRAZOL
SPC Number:

Dates

Filing date:
03/11/1999
Grant date:
02/07/2003
EP Publication Date:
02/07/2003
PCT Publication Date:
18/05/2000
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
22/08/2001
EP B1 Publication Date:
02/07/2003
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
Expiration date:
03/11/2019
Renunciation date:
21/06/2012
Revocation date:
Annulment date:

Owner

From:
03/11/1999
 
 

Name:
AstraZeneca AB
Address:
-, 151 85 Södertälje, Sweden (SE)

Agent

Name:
ARONOVA S.A.
From:
19/09/2003
Address:
PO Box 327, L-4004, ESCH-SUR-ALZETTE, Luxembourg (LU)
To:

Inventor

1

Name:
BERGSTRAND Pontus
Address:
Sweden (SE)

2

Name:
WANG Peter
Address:
Sweden (SE)

Priority

Priority Number:
9803772
Priority Date:
05/11/1998
Priority Country:
Sweden (SE)

Classification

IPC classification:
A61K 9/24; A61K 31/44; A61K 47/38;

Publication

European Patent Bulletin

Issue number:
201907
Publication date:
13/02/2019
Description:
International Patent Classification Changed
Filing date Document type Number of pages